Re-I Chin, Joshua P Schiff, Anup S Shetty, Katrina S Pedersen, Olivia Aranha, Yi Huang, Steven R Hunt, Sean C Glasgow, Benjamin R Tan, Paul E Wise, Matthew L Silviera, Radhika K Smith, Rama Suresh, Kathleen Byrnes, Pamela P Samson, Shahed N Badiyan, Lauren E Henke, Matthew G Mutch, Hyun Kim
BACKGROUND: Short-course radiation therapy and consolidation chemotherapy with nonoperative intent has emerged as a novel treatment paradigm for patients with rectal cancer, but there are no data on the predictors of clinical complete response. OBJECTIVE: To evaluate the predictors of clinical complete response and survival. DESIGN: Retrospective cohort. SETTINGS: NCI-designated cancer center. PATIENTS: Stage I-III rectal adenocarcinoma treated between 01/2018 and 05/2019 (n = 86)...
March 6, 2023: Diseases of the Colon and Rectum